Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures.
about
Imaging in breast cancer: Single-photon computed tomography and positron-emission tomographyImaging metabolic heterogeneity in cancerSemiquantitative analysis of maximum standardized uptake values of regional lymph nodes in inflammatory breast cancer: is there a reliable threshold for differentiating benign from malignant?18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysisPositron emission tomography for benign and malignant disease.Regulation of the Warburg effect in early-passage breast cancer cells.18F-FDG PET/CT imaging in oncologyMolecular Imaging in Breast Cancer - Potential Future Aspects.Clinical applications of FDG-PET in oncology.Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?Defining the role of PET-CT in staging early breast cancer.Overcoming drug resistance and treating advanced prostate cancerPositron emission tomography: clinical applications in oncology. Part 1.Combined approach of perioperative 18F-FDG PET/CT imaging and intraoperative 18F-FDG handheld gamma probe detection for tumor localization and verification of complete tumor resection in breast cancer.Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer.Pulmonary echinococcosis mimicking multiple lung metastasis of breast cancer: the role of fluoro-deoxy-glucose positron emission tomography.Utility of [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in the Initial Staging and Response Assessment of Locally Advanced Breast Cancer Patients Receiving Neoadjuvant ChemotherapyIncidental PET/CT Detection of Breast Cancer in a Patient with Negative Mammogram and Breast Sonogram.The role of PET/CT for evaluating breast cancer.New diagnostic techniques for breast cancer detection.Molecular and functional imaging of breast cancer.ACR appropriateness criteria® locally advanced breast cancer.Diagnostic and prognostic application of positron emission tomography in breast imaging: emerging uses and the role of PET in monitoring treatment response.Clinical application of 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in breast cancer.Imaging of the axilla before preoperative chemotherapy: implications for postmastectomy radiation.Fluorine-18 labeled amino acids for tumor PET/CT imagingEvaluation of nipple aspirate fluid as a diagnostic tool for early detection of breast cancer.Preoperative PET/CT in early-stage breast cancer.Positron emission tomography-computed tomography in the detection of axillary lymph node metastasis in patients with early stage breast cancer.FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy.
P2860
Q24810786-3207DB6D-E399-41BC-B909-33052855651EQ28076500-CC456E89-7986-4863-BBAC-E3F975DCE241Q34026396-3905F078-C68E-48BD-B3B1-E0FA8358CD8CQ34078191-2E60D437-F9FF-431C-877E-3991485D2E43Q34494815-3CD2ABD5-ACB9-4EBA-9832-652A71B3BD2BQ34594985-2D4CC87C-2BEA-4DF8-91FE-A98FBF0AAE63Q35006097-64A0F542-9EF0-4903-8115-CAF7A4CD0069Q35016225-8120F472-3D6D-4A16-A71A-EAF9B16011A3Q35036165-0EE981AB-0B2F-42FF-8567-A592126CDBC0Q35372874-0876433B-5F3F-4C9E-999A-106A49E5CDBBQ35989958-FAEF46C3-E091-49A4-A686-45E8AF688914Q36328812-32292A3C-92E3-4897-87CA-BEDBE0A33617Q36334917-D34A79FE-9D68-4E1E-B19E-90E9210011BFQ36449437-E141BA6C-6F67-4FE9-982B-E81AAB47B175Q36476568-7F61F01E-4008-4D9E-BB08-72C70810E1B6Q36481582-6791268D-B70B-48E4-8055-09728ED812EEQ36734702-E2C627B8-D32A-4D2A-923A-C917A5FDA6B5Q36974140-ECE62811-F769-4232-BFB7-2BDCDD886582Q37062322-B2417F77-BE37-46CB-A3A5-7F934DDEDBE4Q37236424-6C23C929-A467-4885-8EC6-6B55FD581FACQ37776141-4C756C75-D0E4-4B2A-9C03-1BD10FAFB7FCQ37929856-F0D5F6FA-3F86-4973-B1CB-37D56847C6B7Q38090509-FE40EE2B-FFE0-49B9-B179-37AA99F66B70Q38165388-7EB28DD9-1614-43CF-A0A2-E98AAFAC8382Q38257478-D6CDBE1E-0A76-4724-AFFC-B2F2B37A27B6Q41694062-D7896D64-20EB-4832-ACAA-6B95A4344057Q48222816-681640D7-582F-4822-88C9-00CAAA0DA94CQ53174047-08CCBA80-B72E-4E99-B362-993F3C4D5C84Q53362640-DD72E634-77DB-471D-9C49-E1AE0E1ABBFDQ53479198-7731FD0A-5A96-4044-99FE-3408BA85F33F
P2860
Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Fluorine-18 2-deoxy-2-fluoro-D ...... e standard staging procedures.
@en
Fluorine-18 2-deoxy-2-fluoro-D ...... e standard staging procedures.
@nl
type
label
Fluorine-18 2-deoxy-2-fluoro-D ...... e standard staging procedures.
@en
Fluorine-18 2-deoxy-2-fluoro-D ...... e standard staging procedures.
@nl
prefLabel
Fluorine-18 2-deoxy-2-fluoro-D ...... e standard staging procedures.
@en
Fluorine-18 2-deoxy-2-fluoro-D ...... e standard staging procedures.
@nl
P2093
P356
P1476
Fluorine-18 2-deoxy-2-fluoro-D ...... he standard staging procedures
@en
P2093
A Guhlmann
C Santjohanser
H Schirrmeister
R Kreienberg
P2888
P304
P356
10.1007/S002590000448
P577
2001-03-01T00:00:00Z